A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia

Status:
RECRUITING

Trial end date:
2026-08-17

Target enrollment:

Participant gender:

A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

PHASE1

He Huang